Best Grants for HIV / AIDS in American Samoa

The Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance aims to enhance the capacity of ADAPs. By providing essential tools and expert guidance, the program seeks to improve health outcomes for individuals living with HIV in an evolving healthcare landscape. This initiative is funded by the US HHS through the Health Resources & Services Administration, ensuring support and resources are effectively allocated to meet the needs of vulnerable populations.

Research institutions conducting addiction and HIV science in American Samoa can apply for core center funding to build transformative, interdisciplinary research hubs. Focused on substance use, addiction, and HIV, the National Institutes of Health supports centers that integrate existing projects, share resources, foster early-career investigators, and promote collaboration and data sharing across funded teams.

The Academic Research Enhancement Award (AREA) supports small-scale research grants for institutions with limited NIH funding, emphasizing biomedical research experiences for undergraduates. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million in NIH support over the past seven years. This initiative aims to enhance the research environment at these institutions, fostering student involvement in research activities.

The NIDCD is offering funding to advance HIV/AIDS research, particularly focusing on areas related to communication disorders. This initiative supports low-risk clinical trials and encourages researchers to align their proposals with high priority topics identified by the NIH Office of AIDS Research. Applications must be submitted by the local deadline, with optional Letters of Intent due 30 days prior to the proposal deadline. This opportunity aims to enhance understanding and treatment in this crucial health area.

Research institutions and eligible organizations conducting HIV-related basic or translational studies in American Samoa can apply for up to US $275,000 to investigate biological, behavioral, or social mechanisms of HIV pathogenesis. US Dept. of Health & Human Services: National Institutes of Health supports projects on HIV comorbidities, reservoirs, and social determinants within NIDDK’s mission areas.

Biomedical and behavioral HIV researchers working in the context of substance use or substance use disorders in American Samoa can pursue high-risk, high-reward project funding through the Avant Garde Award. The US Dept. of Health & Human Services: National Institutes of Health offers US $350,000 - US $700,000 for pioneering, potentially transformative HIV and SUD research, including early stage investigators.

Research institutions and clinical trial networks studying HIV in infants, children, adolescents, young adults, and maternal populations in American Samoa can access funding via the National Institutes of Health. With a mission to advance HIV and chronic illness research, NIH plans awards up to US $30,000,000 for innovative pediatric and maternal HIV clinical trials.

Research institutions studying hepatitis B and HIV in American Samoa can apply for the National Institutes of Health’s Multidisciplinary Research to Accelerate Hepatitis B Cure awards, offering up to US $8,000,000 for cohort-based, translational research. Projects may benefit HIV/AIDS-focused teams exploring HBV persistence, biomarkers, drug targets, and non-invasive diagnostics.

Public health agencies and research-focused organizations in American Samoa working on HIV/AIDS surveillance and prevention can apply for this federal funding to conduct ongoing bio-behavioral monitoring of populations disproportionately affected by HIV. With a mission to strengthen HIV prevention, Centers for Disease Control & Prevention supports data collection on risk behaviors, testing, and linkage to care.

Research institutions and multidisciplinary scientific teams in American Samoa studying the structural biology of HIV and other infectious diseases can apply for competitive grants from the National Institutes of Health. Funding supports advanced 3D structural analyses, molecular characterization, and structure-guided design of new diagnostics and therapeutics, which may benefit HIV/AIDS-focused programs and researchers.

Organizations planning substance use and HIV prevention or services research in American Samoa can access funding for pilot and feasibility studies supporting future trials. Grants from the National Institutes of Health help develop and test interventions, measures, and methods, with required engagement of end users such as policymakers, practitioners, and people with lived experience.

Research institutions studying HIV-related chronic conditions, coinfections, and comorbidities can access funding through grants from the National Institutes of Health. Early-career investigators may receive support for pioneering HIV prevention and treatment research, including work focused on pediatric and maternal populations, with eligibility extending to American Samoa and other U.S. territories.

American Samoa HIV/AIDS research institutions and investigators studying immunotherapies and brain health can access funding through the National Institutes of Health to evaluate how HIV immunotherapies affect central nervous system outcomes. This R21/R33 opportunity supports biphasic projects examining mechanisms, benefits, and risks, aiming to improve long-term neurologic and cognitive outcomes in people with HIV, with awards up to US $2,000,000.

Research institutions and clinical organizations conducting HIV/AIDS prevention and treatment studies in American Samoa and other eligible regions can access funding through the National Institutes of Health. Grants support participation as Clinical Trials Units within HIV/AIDS Clinical Trials Networks, including clinical research sites, implementation research, and infrastructure to recruit and retain study participants.

Research institutions with capacity to lead HIV clinical trial data operations can apply to manage Statistical and Data Management Centers serving global HIV Clinical Trials Networks, including work impacting American Samoa. American Samoa HIV / AIDS organizations partnering in clinical trials may benefit through improved data systems, monitoring, and analysis supported by the National Institutes of Health.

Research institutions and clinical laboratories working on HIV/AIDS prevention and treatment, including those serving American Samoa, can apply for National Institutes of Health support to operate HIV/AIDS Clinical Trials Network Laboratory Centers. Funding supports laboratory infrastructure, regulatory-compliant testing, data systems, and advanced assays to increase testing capacity for HIV and HIV-related diseases within multi-site clinical trials.

Research institutions focused on HIV/AIDS clinical trials and implementation research can apply to lead a Clinical Trials Network Leadership and Operations Center, including work relevant to American Samoa. Focused on HIV prevention, treatment, and cure strategies across populations, the National Institutes of Health supports LOCs providing scientific leadership and setting research priorities.

The Ryan White HIV/AIDS Program Part D provides supplemental funding aimed at enhancing the infrastructure and capacity of organizations to deliver high-quality, family-centered HIV care services. This initiative focuses on two key areas: HIV Care Innovation and Infrastructure Development, ensuring improved access to essential services for women, infants, children, and youth affected by HIV.

This project aims to enhance health outcomes for women living with HIV in the South by integrating HIV care with comprehensive women's health services through coordinated Clinic and Community Collaboratives. By funding organizations to implement targeted strategies such as culturally responsive services and learning collaboratives, the initiative seeks to improve access to essential health services, increase the number of women initiating rapid ART, and foster sustainable healthcare models that address the unique needs of this population.

This funding opportunity aims to enhance a web-based ordering portal for distributing 1.5 million HIV and STI self-tests to high-burden communities. By optimizing access to these self-tests, the initiative seeks to raise awareness, prevent new infections, and improve the health outcomes of users, thereby contributing to better overall public health and wellbeing.

The HIV Care Grant Program aims to enhance access to comprehensive, high-quality HIV care and treatment for low-income individuals in Pacific Island territories. Funded by the US HHS: Health Resources & Services Administration (HRSA), this initiative supports states and territories in developing effective systems of care, ensuring that those affected by HIV receive the necessary treatment and support to improve health outcomes.

The Ryan White HIV/AIDS Program Part B Supplemental Grant aims to provide essential funding to support HIV care and treatment services across states and territories. This program supplements existing formula-based funding from the RWHAP Part B and ADAP, improving access to necessary resources for those affected by HIV/AIDS. By enhancing support structures, it addresses critical healthcare needs, ensuring better health outcomes for vulnerable populations.

American Samoa HIV / AIDS and other poverty-focused entrepreneurs can access funding through D-Prize to launch new organizations distributing proven interventions, with startup grants up to Up to US $20,000. For-profit ventures, NGOs, and charities in low- and middle-income countries, especially first-time founders with limited prior funding, may be eligible.

The HIV Care Grant Program, funded by the US HHS: Health Resources & Services Administration (HRSA), aims to enhance access to high-quality HIV care and treatment for low-income individuals. This initiative supports states and territories in developing comprehensive systems to address the needs of those living with HIV. By providing essential resources, the program seeks to improve health outcomes and ensure that vulnerable populations receive the necessary support and services.

The Ryan White HIV/AIDS Program Part C Capacity Development Program aims to enhance the capabilities of community-based organizations, focusing on improving health outcomes and decreasing HIV transmission. This initiative supports individuals who have not yet accessed regular HIV care, emphasizing innovative care solutions and infrastructure development to address these critical needs.